Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-24 @ 9:15 PM
NCT ID:
NCT05289804
Eligibility Criteria:
Inclusion Criteria:
* ≥50 years
* Diagnosis of probable aMCI or mild AD
* Montreal Cognitive Assessment between 18-25
* Mini Mental State Examination score \>21
* Stable AChl medication \>3 months
* Adequate visual and auditory acuity
* Capacity to understand and sign informed consent
Exclusion Criteria:
* Any cause of cognitive decline or dementia that is not Alzheimer's disease related including parkinsonism related dementias, vascular dementia, fronto-temporal dementia.
* Enrolment in an ongoing investigational medicinal product study
* History in the past 2 years of epileptic seizures
* Any current major psychiatric disorder
* Evidence of brain damage, including significant trauma, stroke, hydrocephalus, intellectual disability, or serious neurological disorder.
* History of alcoholism or drug abuse within the last 12 months
* Medical devices not eligible for MRI scanning
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT05289804
Study Brief:
Protocol Section:
NCT05289804